These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 10493496)

  • 1. Frequent mutation of beta-catenin and APC genes in primary colorectal tumors from patients with hereditary nonpolyposis colorectal cancer.
    Miyaki M; Iijima T; Kimura J; Yasuno M; Mori T; Hayashi Y; Koike M; Shitara N; Iwama T; Kuroki T
    Cancer Res; 1999 Sep; 59(18):4506-9. PubMed ID: 10493496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent alterations of the beta-catenin and TCF-4 genes, but not of the APC gene, in colon cancers with high-frequency microsatellite instability.
    Fukushima H; Yamamoto H; Itoh F; Horiuchi S; Min Y; Iku S; Imai K
    J Exp Clin Cancer Res; 2001 Dec; 20(4):553-9. PubMed ID: 11876551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exon 3 beta-catenin mutations are specifically associated with colorectal carcinomas in hereditary non-polyposis colorectal cancer syndrome.
    Johnson V; Volikos E; Halford SE; Eftekhar Sadat ET; Popat S; Talbot I; Truninger K; Martin J; Jass J; Houlston R; Atkin W; Tomlinson IP; Silver AR
    Gut; 2005 Feb; 54(2):264-7. PubMed ID: 15647192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular analysis of colorectal cancer tumors from patients with mismatch repair proficient hereditary nonpolyposis colorectal cancer suggests novel carcinogenic pathways.
    Sánchez-de-Abajo A; de la Hoya M; van Puijenbroek M; Tosar A; López-Asenjo JA; Díaz-Rubio E; Morreau H; Caldes T
    Clin Cancer Res; 2007 Oct; 13(19):5729-35. PubMed ID: 17908962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer.
    Sparks AB; Morin PJ; Vogelstein B; Kinzler KW
    Cancer Res; 1998 Mar; 58(6):1130-4. PubMed ID: 9515795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational analysis of the transforming growth factor beta receptor type II gene in hereditary nonpolyposis colorectal cancer and early-onset colorectal cancer patients.
    Shin KH; Park YJ; Park JG
    Clin Cancer Res; 2000 Feb; 6(2):536-40. PubMed ID: 10690536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A beta-catenin mutation in a sporadic colorectal tumor of the RER phenotype and absence of beta-catenin germline mutations in FAP patients.
    Müller O; Nimmrich I; Finke U; Friedl W; Hoffmann I
    Genes Chromosomes Cancer; 1998 May; 22(1):37-41. PubMed ID: 9591632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular genetic alterations and clinical features in early-onset colorectal carcinomas and their role for the recognition of hereditary cancer syndromes.
    Losi L; Di Gregorio C; Pedroni M; Ponti G; Roncucci L; Scarselli A; Genuardi M; Baglioni S; Marino M; Rossi G; Benatti P; Maffei S; Menigatti M; Roncari B; Ponz de Leon M
    Am J Gastroenterol; 2005 Oct; 100(10):2280-7. PubMed ID: 16181381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple epithelial and nonepithelial tumors in hereditary nonpolyposis colorectal cancer: characterization of germline and somatic mutations of the MSH2 gene and heterogeneity of replication error phenotypes.
    Huang RL; Chao CF; Ding DC; Yu CP; Chang CC; Lai HC; Yu MH; Liu HS; Chu TY
    Cancer Genet Cytogenet; 2004 Sep; 153(2):108-14. PubMed ID: 15350299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive characterization of HNPCC-related colorectal cancers reveals striking molecular features in families with no germline mismatch repair gene mutations.
    Abdel-Rahman WM; Ollikainen M; Kariola R; Järvinen HJ; Mecklin JP; Nyström-Lahti M; Knuutila S; Peltomäki P
    Oncogene; 2005 Feb; 24(9):1542-51. PubMed ID: 15674332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A search for germline APC mutations in early onset colorectal cancer or familial colorectal cancer with normal DNA mismatch repair.
    Boardman LA; Schmidt S; Lindor NM; Burgart LJ; Cunningham JM; Price-Troska T; Snow K; Ahlquist DA; Thibodeau SN
    Genes Chromosomes Cancer; 2001 Feb; 30(2):181-6. PubMed ID: 11135435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E2F-4 mutation in hereditary non-polyposis colorectal cancer.
    Moriyama H; Sasamoto H; Kambara T; Matsubara N; Ikeda M; Baba S; Meltzer SJ; Lynch HT; Shimizu K; Tanaka N
    J Exp Clin Cancer Res; 2002 Jun; 21(2):185-9. PubMed ID: 12148576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germline APC mutation on the beta-catenin binding site is associated with a decreased apoptotic level in colorectal adenomas.
    Venesio T; Balsamo A; Scordamaglia A; Bertolaso M; Arrigoni A; Sprujevnik T; Rossini FP; Risio M
    Mod Pathol; 2003 Jan; 16(1):57-65. PubMed ID: 12527714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of Icat induces G(2) arrest and cell death in tumor cell mutants for adenomatous polyposis coli, beta-catenin, or Axin.
    Sekiya T; Nakamura T; Kazuki Y; Oshimura M; Kohu K; Tago K; Ohwada S; Akiyama T
    Cancer Res; 2002 Jun; 62(11):3322-6. PubMed ID: 12036951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of somatic APC mutations in rare extracolonic tumors of patients with familial adenomatous polyposis coli.
    Bläker H; Sutter C; Kadmon M; Otto HF; Von Knebel-Doeberitz M; Gebert J; Helmke BM
    Genes Chromosomes Cancer; 2004 Oct; 41(2):93-8. PubMed ID: 15287021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of somatic molecular changes, clinicopathological features, family history, and germline mutations in colorectal cancer families: evidence for efficient diagnosis of HNPCC and for the existence of distinct groups of non-HNPCC families.
    Johnson V; Lipton LR; Cummings C; Eftekhar Sadat AT; Izatt L; Hodgson SV; Talbot IC; Thomas HJ; Silver AJ; Tomlinson IP
    J Med Genet; 2005 Oct; 42(10):756-62. PubMed ID: 15788729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No evidence for involvement of beta-catenin and APC in urothelial carcinomas.
    Stoehr R; Krieg RC; Knuechel R; Hofstaedter F; Pilarsky C; Zaak D; Schmitt R; Hartmann A
    Int J Oncol; 2002 May; 20(5):905-11. PubMed ID: 11956582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [beta-Catenine as a genomic target of high-grade microsatellite instability in colorectal cancer].
    Kölble K; Barthel B; Ullrich O; Pidde H; Döhring C; Rüschoff J; Schlag PM; Dietel M
    Verh Dtsch Ges Pathol; 2000; 84():182-6. PubMed ID: 11217439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-catenin mutations in hepatocellular carcinoma correlate with a low rate of loss of heterozygosity.
    Legoix P; Bluteau O; Bayer J; Perret C; Balabaud C; Belghiti J; Franco D; Thomas G; Laurent-Puig P; Zucman-Rossi J
    Oncogene; 1999 Jul; 18(27):4044-6. PubMed ID: 10435629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel germline mutation (300-305delAGTTGA) in the human MSH2 gene in hereditary non-polyposis colorectal cancer (HNPCC).
    Glasl S; Papatheodorou L; Baretton G; Jung C; Gross M
    Hum Mutat; 2000 Jul; 16(1):91-2. PubMed ID: 10874318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.